Hainan Shuangcheng Pharmaceuticals Gestione

Gestione criteri di controllo 3/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Jianming Li

Amministratore delegato

CN¥828.0k

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	4.8yrs
Proprietà del CEO	0.4%
Durata media del management	1.8yrs
Durata media del Consiglio di amministrazione	4.8yrs

Aggiornamenti recenti sulla gestione

Recent updates

Subdued Growth No Barrier To Hainan Shuangcheng Pharmaceuticals Co., Ltd.'s (SZSE:002693) Price

Aug 03

Getting In Cheap On Hainan Shuangcheng Pharmaceuticals Co., Ltd. (SZSE:002693) Is Unlikely

Apr 15

AMMINISTRATORE DELEGATO

Jianming Li (68 yo)

4.8yrs

Mandato

CN¥828,000

Compensazione

Mr. Jianming Li serves as an General Manager of Hainan Shuangcheng Pharmaceutical Co., Ltd. and serves as its Non-Independent director since January 16, 2020. He served as Executive Deputy General Manager...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Jianming Li	GM & Non-Independent Director	no data	CN¥828.00k	0.42% CN¥ 42.9m
Xuguang Wang	Financial Director & Chief Financial Officer	14yrs	CN¥380.00k	0.17% CN¥ 17.1m
Xiaofeng Yu	Deputy GM & Secretary of the Board	14yrs	CN¥380.00k	0.16% CN¥ 16.4m
Jianlin Yuan	Deputy General Manager	no data	CN¥494.80k	0.15% CN¥ 15.1m
Zhong Yao	Deputy General Manager	1.8yrs	CN¥833.20k	0.078% CN¥ 7.9m
Shiying Wang	Deputy General Manager	1.8yrs	CN¥367.40k	0.030% CN¥ 3.0m
Yixiang Ai	Deputy General Manager	1.8yrs	CN¥362.80k	0.017% CN¥ 1.8m
Haiyan Li	Deputy General Manager	1.8yrs	CN¥332.60k	0.013% CN¥ 1.3m
Rui Wang	Deputy General Manager	1.8yrs	CN¥332.20k	0.015% CN¥ 1.5m
Yuan Li	Deputy General Manager	1.8yrs	CN¥362.30k	0.016% CN¥ 1.6m
Yun Zhou	Accounting Supervisor	no data	Nessun dato	Nessun dato

1.8yrs

Durata media

45yo

Età media

Gestione esperta: Il team dirigenziale di 002693 non è considerato esperto (durata media 1.8 anni), il che suggerisce un nuovo team.

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Jianming Li	GM & Non-Independent Director	4.8yrs	CN¥828.00k	0.42% CN¥ 42.9m
Chengdong Wang	Chairman	14yrs	Nessun dato	0.51% CN¥ 51.7m
Yingpu Wang	Vice Chairman	14yrs	CN¥796.00k	15.58% CN¥ 1.6b
Bin Fu	Non-Employee Supervisor	14yrs	Nessun dato	Nessun dato
Jing Bai	Vice Chairman	2.8yrs	Nessun dato	Nessun dato
Hongyu Wang	Chairman of the Supervisory Board	7.8yrs	Nessun dato	Nessun dato
Jianwei Li	Independent Director	1.8yrs	CN¥60.00k	Nessun dato
Jianhua Xiao	Independent Director	1.8yrs	CN¥60.00k	Nessun dato
Ying Chen	Non-Employee Supervisor	1.8yrs	Nessun dato	Nessun dato

4.8yrs

Durata media

48yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 002693 sono considerati esperti (durata media dell'incarico 4.8 anni).

Hainan Shuangcheng Pharmaceuticals Gestione

Gestione criteri di controllo 3/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Hainan Shuangcheng Pharmaceuticals Co., Ltd., Annual General Meeting, May 22, 2024

Less than half of directors are independent

Hainan Shuangcheng Pharmaceuticals Co., Ltd. Announces Board Appointments

Hainan Shuangcheng Pharmaceuticals Co., Ltd., Annual General Meeting, May 06, 2022

Hainan Shuangcheng Pharmaceuticals Co., Ltd. Elects Bai Jing as Non-Independent Director

Recent updates

Third quarter 2024 earnings released: CN¥0.05 loss per share (vs CN¥0.024 loss in 3Q 2023)

Hainan Shuangcheng Pharmaceuticals Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024

New major risk - Share price stability

New major risk - Revenue and earnings growth

Subdued Growth No Barrier To Hainan Shuangcheng Pharmaceuticals Co., Ltd.'s (SZSE:002693) Price

Hainan Shuangcheng Pharmaceuticals Co., Ltd. to Report First Half, 2024 Results on Aug 29, 2024

Hainan Shuangcheng Pharmaceuticals Co., Ltd., Annual General Meeting, May 22, 2024

First quarter 2024 earnings released: CN¥0.021 loss per share (vs CN¥0.011 profit in 1Q 2023)

Getting In Cheap On Hainan Shuangcheng Pharmaceuticals Co., Ltd. (SZSE:002693) Is Unlikely

Hainan Shuangcheng Pharmaceuticals Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024

New major risk - Share price stability

Hainan Shuangcheng Pharmaceuticals Co., Ltd. to Report Fiscal Year 2023 Results on Apr 30, 2024

New major risk - Share price stability

Third quarter 2023 earnings released: CN¥0.024 loss per share (vs CN¥0.006 loss in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.01 (vs CN¥0.006 loss in 2Q 2022)

Full year 2022 earnings released: EPS: CN¥0.02 (vs CN¥0.05 loss in FY 2021)

Less than half of directors are independent

Hainan Shuangcheng Pharmaceuticals Co., Ltd. Announces Board Appointments

Third quarter 2022 earnings released: CN¥0.006 loss per share (vs CN¥0.024 loss in 3Q 2021)

Second quarter 2022 earnings released: CN¥0.006 loss per share (vs CN¥0.023 profit in 2Q 2021)

First quarter 2022 earnings released: EPS: CN¥0.002 (vs CN¥0.008 loss in 1Q 2021)

Hainan Shuangcheng Pharmaceuticals Co., Ltd., Annual General Meeting, May 06, 2022

Full year 2021 earnings released: CN¥0.05 loss per share (vs CN¥0.13 loss in FY 2020)

Hainan Shuangcheng Pharmaceuticals Co., Ltd. Elects Bai Jing as Non-Independent Director

Third quarter 2021 earnings released: CN¥0.94 loss per share (vs CN¥0.02 loss in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.011 (vs CN¥0.036 loss in 2Q 2020)

Full year 2020 earnings released: CN¥0.13 loss per share (vs CN¥0.06 profit in FY 2019)

Hainan Shuangcheng Pharmaceuticals Co., Ltd. to Report Fiscal Year 2020 Results on Apr 21, 2021

New 90-day low: CN¥3.69

New 90-day low: CN¥3.91

New 90-day low: CN¥4.45

Third quarter earnings released

New 90-day low: CN¥4.84

Hainan Shuangcheng Pharmaceuticals Co., Ltd. to Report Q3, 2020 Results on Oct 28, 2020

New 90-day low: CN¥5.00

Hainan Shuangcheng Pharmaceuticals Co., Ltd. to Report First Half, 2020 Results on Aug 21, 2020

AMMINISTRATORE DELEGATO

Mandato

Compensazione

Gruppo dirigente

Durata media

Età media

Membri del Consiglio di amministrazione

Durata media

Età media